Document Detail

Atomoxetine use during a period of FDA actions.
MedLine Citation:
PMID:  23047788     Owner:  NLM     Status:  In-Data-Review    
CONTEXT: : The Food and Drug Administration (FDA) issued a Public Health Advisory entitled "Suicidal Thinking in Children and Adolescents Being Treated with Strattera (Atomoxetine)" on September 29, 2005. At FDA's request, the manufacturer subsequently added a boxed warning to the drug's labeling on November 8, 2005.
OBJECTIVE: : To evaluate whether the boxed warning for suicidal thinking in atomoxetine's labeling was associated with a change in the pattern of attention-deficit/hyperactivity disorder (ADHD) medication use.
METHODS: : Patients who had an ADHD diagnosis and were prescribed either atomoxetine or stimulants between January 2004 and December 2007 were selected from IMS LifeLink Health Plan Claims database. In this ecologic analysis, the outcome measure is the incident atomoxetine use rate, defined as the proportion of atomoxetine incident users among all initial ADHD pharmacotherapy users. The impact of the boxed warning was evaluated using interrupted time series analysis.
RESULTS: : A total of 16,311 patients met the definition of incident ADHD medication users. The incident atomoxetine use rate decreased from January 2004 to September 2005 among all age groups (range, -0.45% to -0.74%); and the rate among adult patients decreased by 11.89% (95% confidence interval, 3.05%-20.74%) from September 2005 to November 2005. No long-term impact was detected.
CONCLUSIONS: : Significant decline of the atomoxetine use rate was observed before the boxed warning in all age groups. No significant change was detected in the atomoxetine use rate among targeted children or adolescents after the FDA's boxed warning concerning suicidal thinking.
Dongyi Tony Du; Esther H Zhou; John Goldsmith; Clark Nardinelli; Tarek A Hammad
Related Documents :
24677838 - A88: tocilizumab: a practical experience from a north indian centre.
10986878 - Overview of rotavirus infections in korea.
16008618 - Non-typhi salmonella gastroenteritis in children presenting to the emergency department...
23406068 - The impact of serological features in chinese children with primary or past epstein--ba...
8039368 - Levels of causal understanding in chimpanzees and children.
22231288 - Remission, minimal disease activity and acceptable symptom state in juvenile idiopathic...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Medical care     Volume:  50     ISSN:  1537-1948     ISO Abbreviation:  Med Care     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-10     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0230027     Medline TA:  Med Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  987-92     Citation Subset:  IM    
*Office of Commissioner, US Food and Drug Administration (FDA) †Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA).
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The Drug Safety and Risk Management Advisory Committee: A Case Study of Meeting Frequency, Content, ...
Next Document:  Development and Dissemination of a Statewide System to Minimize Use of Potentially Inappropriate Med...